Home / Research Library / Immune checkpoint inhibitors in melanoma
🧬 Medicine & Biology OpenAlex

Immune checkpoint inhibitors in melanoma

📅 September 1, 2021 👤 Matteo S. Carlino, James Larkin, Georgina V. Long 📖 The Lancet 📊 1,182 citations

🤖 Plain-English Summary

This research explores Immune checkpoint inhibitors in melanoma, contributing new insights to the field of Medicine & Biology.

🔑 Key Findings

  • Research demonstrates significant advances in patient outcome data
  • Study provides new evidence regarding clinical efficacy results
  • Findings open new directions for biological mechanism insights

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Sep 01, 2021
Journal The Lancet
Authors Matteo S. Carlino, James Larkin, Georgina V. Long
DOI 10.1016/s0140-6736(21)01206-x
Citations 1,182
Source OpenAlex

More 🧬 Medicine & Biology Research